Product Information

LOJAIMIESS 0.1-0.02-0.01 TAB is a generic product labeled by Xiromed LLC, priced at $0.2395 per EA under NDC 70700020793. Its NADAC has been published 47 times since Oct 1, 2025.

FDA first approved this application on Jun 17, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

Manufacturer

Xiromed LLC

NDC

70700020793

Classification

Generic

Dosage Form

KIT

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA200493

FDA Approved

6/17/2015

TE Code

AB

On Market Since

1/29/2025

Price Statistics

The NADAC for LOJAIMIESS 0.1-0.02-0.01 TAB has been published 47 times since Oct 1, 2025, and over the history we have for it it has risen 11.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2395 per EA
All-time high$0.2436 (Jul 15, 2026)
All-time low$0.1911 (Dec 17, 2025)
52-week high$0.2436
52-week low$0.1911
Median price$0.2148
Average price$0.2199
Largest weekly change-7.0% (Nov 19, 2025)
Weeks tracked47
Tracking sinceOct 1, 2025

Price History

1W

+1.0%

1M

+1.0%

3M

-0.9%

6M

+12.1%

1Y

N/A

3Y

N/A

5Y

N/A

All

+11.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Levonorgestrel and Ethinyl Estradiol and Ethinyl Estradiol tablets market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of LOJAIMIESS 0.1-0.02-0.01 TAB?

The current National Average Drug Acquisition Cost (NADAC) for LOJAIMIESS 0.1-0.02-0.01 TAB, manufactured by Xiromed LLC, is $0.2395 per EA (NDC 70700020793), effective Aug 19, 2026.

How has the price of LOJAIMIESS 0.1-0.02-0.01 TAB changed over time?

Over the history we have for it, the NADAC for LOJAIMIESS 0.1-0.02-0.01 TAB has risen 11.5%. It has been tracked across 47 weekly CMS publications since Oct 1, 2025.

What are the highest and lowest recorded NADAC prices for LOJAIMIESS 0.1-0.02-0.01 TAB?

Since Oct 1, 2025, the NADAC for LOJAIMIESS 0.1-0.02-0.01 TAB has ranged from a low of $0.1911 (Dec 17, 2025) to a high of $0.2436 (Jul 15, 2026), with a median of $0.2148 per EA.

Are there cheaper alternatives to LOJAIMIESS 0.1-0.02-0.01 TAB?

No other NADAC-published product currently shares the active ingredient and strength of LOJAIMIESS 0.1-0.02-0.01 TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LOJAIMIESS 0.1-0.02-0.01 TAB?

LOJAIMIESS 0.1-0.02-0.01 TAB (NDC 70700020793) is labeled by Xiromed LLC, and CMS classifies it as a generic product.